Nuveen Asset Management’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $7.31M | Buy |
212,351
+8,193
| +4% | +$282K | ﹤0.01% | 1775 |
|
|
2024
Q3 | $8.17M | Hold |
204,158
| – | – | ﹤0.01% | 1736 |
|
|
2024
Q2 | $6.16M | Sell |
204,158
-199,211
| -49% | -$6.01M | ﹤0.01% | 1841 |
|
|
2024
Q1 | $13.5M | Buy |
403,369
+677
| +0.2% | +$22.7K | ﹤0.01% | 1414 |
|
|
2023
Q4 | $13M | Sell |
402,692
-83,299
| -17% | -$2.69M | ﹤0.01% | 1419 |
|
|
2023
Q3 | $15.9M | Buy |
485,991
+79
| +0% | +$2.59K | 0.01% | 1177 |
|
|
2023
Q2 | $17.1M | Buy |
485,912
+116,784
| +32% | +$4.11M | 0.01% | 1176 |
|
|
2023
Q1 | $12.1M | Sell |
369,128
-6,874
| -2% | -$224K | ﹤0.01% | 1366 |
|
|
2022
Q4 | $20.7M | Sell |
376,002
-47,253
| -11% | -$2.6M | 0.01% | 1023 |
|
|
2022
Q3 | $18.7M | Sell |
423,255
-69,961
| -14% | -$3.1M | 0.01% | 1057 |
|
|
2022
Q2 | $24.1M | Buy |
493,216
+92,130
| +23% | +$4.49M | 0.01% | 921 |
|
|
2022
Q1 | $19.8M | Buy |
401,086
+17,092
| +4% | +$842K | 0.01% | 1206 |
|
|
2021
Q4 | $16.4M | Sell |
383,994
-77,272
| -17% | -$3.29M | ﹤0.01% | 1353 |
|
|
2021
Q3 | $17.7M | Buy |
461,266
+128,521
| +39% | +$4.93M | 0.01% | 1355 |
|
|
2021
Q2 | $9.39M | Buy |
332,745
+276,981
| +497% | +$7.82M | ﹤0.01% | 1909 |
|
|
2021
Q1 | $1.84M | Buy |
55,764
+45,607
| +449% | +$1.51M | ﹤0.01% | 2658 |
|
|
2020
Q4 | $367K | Buy |
+10,157
| New | +$367K | ﹤0.01% | 3106 |
|